-
Amyloid Beta ( 38-42 ) ( 44A3 ) Aβ Anti-Human Mouse IgG MoAb
Alzheimer's disease (AD) is characterized by the presence of extracellular plaques and intracellular neurofibrillary tangles (NFTs) in the brain. The major protein component of these plaques is beta amyloid (Aβ) peptide, a 40 to 43 amino acid...
Add to Cart$550.00 -
Amyloid Beta ( 38-42 ) ( 44A3 ) Aβ Anti-Human Mouse IgG MoAb 1
Alzheimer's disease (AD) is characterized by the presence of extracellular plaques and intracellular neurofibrillary tangles (NFTs) in the brain. The major protein component of these plaques is beta amyloid (Aβ) peptide, a 40 to 43 amino acid...
Add to Cart$132.00 -
Amyloid Beta ( N ) ( 82E1 ) Aβ Anti-Human Mouse IgG MoAb Biotin 1
Alzheimer’s disease (AD) is characterized by the presence of extracellular plaques and intracellular neurofibrillary tangles (NFTs) in the brain. The major protein component of these plaques is beta amyloid peptide (Aβ), a 40 to 43 amino acid...
Add to Cart$132.00 -
Amyloid Beta (N) (82E1) Aβ Anti-Human Mouse IgG MoAb
Alzheimer's disease (AD) is characterized by the presence of extracellular plaques and intracellular neurofibrillary tangles (NFTs) in the brain. The major protein component of these plaques is beta amyloid (Aβ) peptide, a 40 to 43 amino acid...
Add to Cart$550.00 -
Amyloid Beta (N) (82E1) Aβ Anti-Human Mouse IgG MoAb 1
Alzheimer's disease (AD) is characterized by the presence of extracellular plaques and intracellular neurofibrillary tangles (NFTs) in the brain. The major protein component of these plaques is beta amyloid (Aβ) peptide, a 40 to 43 amino acid...
Add to Cart$132.00 -
Amyloid Beta (N) (82E1) Aβ Anti-Human Mouse IgG MoAb Biotin
Alzheimer's disease (AD) is characterized by the presence of extracellular plaques and intracellular neurofibrillary tangles (NFTs) in the brain. The major protein component of these plaques is beta amyloid (Aβ) peptide, a 40 to 43 amino acid...
Add to Cart$550.00 -
Amyloid Beta (N3pE) (8E1) Aβ Anti-Human Mouse IgG MoAb
The first case of Alzheimer's disease (AD) was reported by Dr. A. Alzheimer, the German neuropathologist in 1907. The plaques which appear in the brains of AD patients mostly consist of Amyloidβ protein and it has been considered as...
Add to Cart$550.00 -
Amyloid Beta (N3pE) (8E1) Aβ Anti-Human Mouse IgG MoAb 1
The first case of Alzheimer's disease (AD) was reported by Dr. A. Alzheimer, the German neuropathologist in 1907. The plaques which appear in the brains of AD patients mostly consist of Amyloidβ protein and it has been considered as...
Add to Cart$132.00 -
Amyloid Beta E22P ( 11A1 ) Aβ Anti-Human Mouse IgG MoAb
Alzheimer’s disease (AD) is characterized by the presence of extracellular plaques and intracellular neurofibrillary tangles (NFTs) in the brain. Aggregation of the 42-mer amyloid β-protein (Aβ42) plays a critical role in the pathogenesis...
Add to Cart$550.00 -
Amyloid Beta E22P ( 11A1 ) Aβ Anti-Human Mouse IgG MoAb 1
Alzheimer’s disease (AD) is characterized by the presence of extracellular plaques and intracellular neurofibrillary tangles (NFTs) in the brain. Aggregation of the 42-mer amyloid β-protein (Aβ42) plays a critical role in the pathogenesis...
Add to Cart$132.00 -
Angiotensinogen (104AT 601.2.80) Anti-Human Mouse IgG MoAb
Angiotensinogen is the precursor of angiotensin and is cleaved into angiotensin I and II in the renin-angiotensin system, and it has long been reported to play an important role in controlling blood pressure. In recent years interest related to the role...
Add to Cart$550.00 -
Angiotensinogen (104AT 601.2.80) Anti-Human Mouse IgG MoAb 1
Angiotensinogen is the precursor of angiotensin and is cleaved into angiotensin I and II in the renin-angiotensin system, and it has long been reported to play an important role in controlling blood pressure. In recent years interest related to the role...
Add to Cart$132.00
Monoclonal Antibodies
Monoclonal antibodies (mAb or moAb) are derived from a single B-cell parent clone and therefore only recognize a single epitope per antigen.
These B-cells are immortalized by fusion with hybridoma cells, allowing for long-term generation of identical monoclonal antibodies.
Monoclonal antibodies specifically detect a particular epitope on the antigen and therefore are less likely than polyclonal antibodies to cross-react with other proteins.
IBL-America offers a wide range of monoclonal antibodies that can be used in the research and development of multiple laboratory testing applications.